ACLY and autoimmune polyendocrinopathy: In patients without APS, the prevalence of elevated titers of aCL was found to be ~10% of patients with acute MI, and twofold higher (21%) in post-MI patients with persistently elevated titers of aCL and under 45 years of age (64, 68).